Connection

Toru Hifumi to Coronavirus Infections

This is a "connection" page, showing publications Toru Hifumi has written about Coronavirus Infections.
Connection Strength

0.035
  1. Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients. Crit Care. 2020 08 12; 24(1):497.
    View in: PubMed
    Score: 0.028
  2. The application of 6S in the care of COVID-19 patients: a Japanese perspective. Crit Care. 2020 09 01; 24(1):542.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.